Dare Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
Dare Bioscience, Inc. (Nasdaq: DARE), an emerging growth company incorporated in Delaware, filed this Current Report on May 14, 2019. The filing announces the financial results for the first quarter ended March 31, 2019.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. The document serves as a notification that Q1 2019 results have been issued.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, contingencies, and unusual items are not detailed in the Form 8-K text. The registrant notes that the information is furnished and not filed for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 14, 2019) for actual Q1 2019 financial figures.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm the trading symbol (DARE) and exchange (Nasdaq Capital Market) for current market data.